The Society's Journal Membership Services APS Symposia 25th APS Symposium
About APS
Presidents of the American Peptide Society
Member Benefits
Current News
The Society's Journal
Photo Gallery
APS Calendar
Worldwide Events
In Memoriam
Contact Us

FASEB Services for the American Peptide Society

The American Peptide Society (APS) is a member of the Federation of American Societies for Experimental Biology (FASEB), a coalition of 27 scientific societies representing over 120,000 biological and biomedical researchers from around the world. FASEB promotes research and education in the biological and biomedical sciences, and it has become an internationally recognized organization that legislators, federal agencies, and the media turn to for information on policies related to biomedical science and engineering.

FASEB’s elected leaders and staff meet regularly with members of Congress, congressional staff, and federal agency officials to provide the prospective of the membership on a wide range of issues. These positions are developed by the working scientists representing FASEB member societies and reflect the views of a broad cross-section of the research community.

APS Representatives to FASEB:

  • Maurice Manning, PhD, DSc, FASEB Board Representative
    Dr. Manning is a Distinguished University Professor in the Department of Biochemistry and Cancer Biology at the University of Toledo College of Medicine and Life Sciences in Toledo, Ohio. He was also one of the founding councilors of APS.

  • J. Mark Carter, PhD, FASEB Science Policy Committee Representative
    Dr. Carter is Research Chemist for Produce Safety and Microbiology Research at the USDA Agricultural Research Service in Albany, CA.

Click here to learn more about our various subcommittees addressing issues important to scientists.

FASEB helps society members play an active role in advocating for issues relevant to their fields. We provide the advocacy tools and information you need for contacting elected officials and the media. Click here to learn more about our advocacy resources.


FASEB’s Office of Public Affairs (OPA) publishes reports, articles, and essays to help keep its member societies and other scientific organizations abreast of policies impacting biological and biomedical sciences. These include:

  • The Washington Update, a biweekly newsletter, featuring FASEB public affairs activities and reports, the “inside scoop” on Capitol Hill science policy issues, the FASEB “Society Spotlight,” and highlights of relevant science agency news and meetings

  • Breakthroughs in Bioscience, a series of essays that illustrate recent breakthroughs in biomedical research and their importance to society

  • Horizons in Bioscience, a series of shorter essays describing scientific discoveries on the brink of clinical application

Data Compilations

As part of FASEB’s effort to inform the policy development process, the Office of Public Affairs collects, compiles, and analyzes information relevant to biomedical research policy.

Legislative Affairs

One of our top priorities is urging Congress to provide sustainable and predictable federal funding for science research. But it is not enough for national organizations like FASEB to advocate on behalf of science—elected officials want to hear from their own constituents! Join FASEB’s advocacy efforts to help ensure the United States continues to be a hub for innovation and scientific discovery. The resources below have been specifically designed to help scientists and their colleagues request a meeting with their members of Congress, use social media to connect with elected officials, attend a town hall meeting, or submit an op-ed to a local newspaper.

Science Policy

FASEB focuses on key policy issues affecting biomedical researchers and their life-saving work. The diversity of our membership allows us to draw on the expertise of scientists to comment thoughtfully and decisively on issues of concern to research.

At FASEB, policy development begins with the working scientists representing FASEB member societies and reflects the views of a broad cross-section of the research community. Click here to view a full description and list of subcommittees.